Form 8-K - Current report:
SEC Accession No. 0001641172-25-002009
Filing Date
2025-04-01
Accepted
2025-04-01 09:00:36
Documents
17
Period of Report
2025-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48448
2 ex99-1.htm EX-99.1 54941
3 ex99-1_002.jpg GRAPHIC 112802
4 ex99-1_001.jpg GRAPHIC 16080
  Complete submission text file 0001641172-25-002009.txt   517440

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE rnxt-20250401.xsd EX-101.SCH 3260
6 XBRL DEFINITION FILE rnxt-20250401_def.xml EX-101.DEF 29597
7 XBRL LABEL FILE rnxt-20250401_lab.xml EX-101.LAB 35952
8 XBRL PRESENTATION FILE rnxt-20250401_pre.xml EX-101.PRE 26654
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5193
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 25796899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)